Pay in 4 interest-free payments of $6.61 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
Viking Therapeutics (VKTX): The pure-play GLP-1 development company reported promising Phase 2 data for its own obesity candidate, VK2735
Potential direct anti-inflammatory mechanisms from preclinical and early clinical studies include: Modulation of immune cell function : GLP-1 receptor activation may reduce pro-inflammatory cytokine production from macrophages and other immune cells Reduction of oxidative stress : These medications may decrease reactive oxygen species production, which contributes to inflammatory processes Endothelial protection : GLP-1 receptor agonists may improve endothelial function and reduce vascular inflammation Inhibition of inflammatory signalling pathways : Including suppression of nuclear factor-kappa B (NF-B), a key regulator of inflammatory gene expression It's important to note that many of these mechanisms have been primarily demonstrated in laboratory or animal studies, with more limited evidence in humans
Yes, tirzepatide can indirectly cause menstrual irregularities through significant weight loss and metabolic changes that affect reproductive hormone balance
To further delineate the mechanism in the PVN necessary for the insulin regulation by the OB GLP-1 system, we administered the GABA A receptor antagonist bicuculline locally in the PVN
Cleveland Clinic notes that dehydration is a common side effect of overly large calorie deficits and can contribute to fatigue. Move Smarter, Not Harder Feeling tired does not mean strength training has to stop
US$ 25.80
US$ 28.63
US$ 28.12
US$ 25.95
US$ 23.23
US$ 25.18
US$ 20.57
